Relationships among slow diffusion coefficient and diffusion-derived ‘vessel density’ signal features, Gadoxetate delayed enhancement, tumor size, tumor grading, and patient survival: an exploratory study of mass-forming intrahepatic cholangiocarcinoma
Abstract
Background: Intrahepatic cholangiocarcinoma (ICC) literature suggests that hypervascularity on arterial contrast agent enhancement (CE) is associated with better prognosis, while rich stroma is associated with poorer prognosis. This exploratory study evaluates the relationships among slow diffusion coefficient (SDC) and diffusion-derived 'vessel density' (DDVD) signal features, Gadoxetate delayed enhancement, and survival in patients with mass-forming ICC. An ICC with higher SDC may be associated with potentially better patient survival due to less stromal fibrosis. Methods: images (Center 2). Relative to the liver signal, tumor SDC and DDVD signals were assigned to six semi-quantitative score (SQS) categories: low signal (scored as '0'), iso-signal (scored as '1'), slightly high signal (scored as '1.5'), high signal (scored as '2'), higher signal (scored as '2.5'), and markedly high signal (scored as '3'). SDC and ADC were also quantitatively measured. Delayed phase magnetic resonance imaging (MRI) scan was obtained at a median of 3 min 51 sec after the contrast agent injection. Percentage area of CE during delayed phase ('% delay CE') was estimated visually and also quantified with the spleen CE signal intensity as the reference. Follow-up data were available in 20 cases from Center 1 (n=9 alive till the last follow-up, n=11 died during the follow-up), and we conducted additional histopathological grading for 14 cases from Center 1. Results: , and an additional patient had an advanced age of 76 years. Conclusions: in the largest section) are associated with better survival potential. ICCs with lower SDC score (≤2.0) are likely associated with a poor prognosis.
Fields of Study & Subjects
MRI in cancer diagnosis
Cholangiocarcinoma and Gallbladder Cancer Studies
Gallbladder and Bile Duct Disorders
Publication details
- Journal / source
- Journal of Gastrointestinal Oncology
- Publisher
- AME Publishing Company
- Volume
- 17
- Issue
- 4
- Pages
- 253–253
- Publication date
- 13 July 2026
- Language
- EN